Kaplan–Meier curve analyses and statistical tests showed that in the four glioma datasets, the overall survival (OS) rate of patients with high hepcidin expression was significantly lower than that of patients with low hepcidin expression in glioma (p < 0.001) (Figure 2B). This evidence concerns the gene HAMP and glioma.